Tag: Prescription Drugs
Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension
Reduction in blood pressure greater with lorundrostat versus placebo in patients receiving two to five medications with BP ≥140/90 mm Hg
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists
Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis
Patients with psoriatic arthritis are less likely to begin disease-modifying antirheumatic drug therapy
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
Findings seen among 33,995 individuals aged 40 years and older with untreated hypertension
Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use
Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction
In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins
Efanesoctocog Alfa Not Cost-Effective for Prophylaxis in Hemophilia A
Efanesoctocog alfa needs to be priced at <53 and <59 percent of current price for conventional and distributional cost-effectiveness
Common Medications Tied to Older Age at Onset of Parkinson Disease
Almost 10-year delay seen for patients who were started on adrenergic blockers before onset of PD symptoms
School-Based Asthma Therapy Boosts Asthma Control, Cuts Acute Health Care Use
Program also helps close health disparities gap for Black and Latino children at high risk for poor asthma outcomes
